{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(11)"],"submitter":["Taylor M"],"pubmed_abstract":["<h4>Importance</h4>The prevalence of depression is higher in cancer survivors than in the general population. As the long-term cancer survivor population increases, it is increasingly important to understand risk factors for late-onset depression.<h4>Objective</h4>To identify risk factors associated with late-onset depression in long-term (5-year) survivors of breast, prostate, or colorectal cancer.<h4>Design, setting, and participants</h4>This retrospective cohort study used 2022 linkage of Surveillance, Epidemiology, and End Results (SEER) and Medicare data to identify 5-year survivors of breast, prostate, or colorectal cancer 66 years or older who were enrolled in fee-for-service Medicare and had no previous depression diagnosis. Long-term survivors were diagnosed with cancer between Ja"],"journal":["JAMA network open"],"pagination":["e2544812"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12658655"],"repository":["biostudies-literature"],"pubmed_title":["Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer."],"pmcid":["PMC12658655"],"pubmed_authors":["Yasin F","Spees L","Wang SY","Dinan MA","Cecchini M","Oeffinger K","Gross CP","Taylor M","Silber A","Leeds I","Westvold SJ","Hyslop T","Leapman MS","Wheeler SB","Long JB","Kwaramba T","Forman R"],"additional_accession":[]},"is_claimable":false,"name":"Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer.","description":"<h4>Importance</h4>The prevalence of depression is higher in cancer survivors than in the general population. As the long-term cancer survivor population increases, it is increasingly important to understand risk factors for late-onset depression.<h4>Objective</h4>To identify risk factors associated with late-onset depression in long-term (5-year) survivors of breast, prostate, or colorectal cancer.<h4>Design, setting, and participants</h4>This retrospective cohort study used 2022 linkage of Surveillance, Epidemiology, and End Results (SEER) and Medicare data to identify 5-year survivors of breast, prostate, or colorectal cancer 66 years or older who were enrolled in fee-for-service Medicare and had no previous depression diagnosis. Long-term survivors were diagnosed with cancer between Ja","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-06-05T20:35:39.586Z","creation":"2026-05-21T03:12:54.418Z"},"accession":"S-EPMC12658655","cross_references":{"pubmed":["41296485"],"doi":["10.1001/jamanetworkopen.2025.44812"]}}